Autopsy report · NCT05501171

Psychological Mobile App for Patients With AML

“the funding agency (blue note therapeutics) pulled out and did not provide funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 months before it stopped.
• 11 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

AML; Acute Myeloid Leukemia

Interventions

DREAMLAND; CERENA

Participants

11

Sites

3

Countries

United States

Trials that died the same way

• Taxotere-Enoxaparin-(ENOXA)-Study
  “The external funding (pharmaceutical company) was stopped and could not be substituded by internal funding.” (63% match in meaning)
• P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis
  “Grant not funded so clinical trial not started.” (61% match in meaning)
• HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
  “Was not approved by funding organization” (61% match in meaning)
• A Breathing-Based Meditation Intervention for Patients With Treatment Resistant Late Life Depression
  “Funding was not received.” (60% match in meaning)
• Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
  “Funding was not acquired” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.